ro 32-3555 has been researched along with melagatran in 1 studies
Studies (ro 32-3555) | Trials (ro 32-3555) | Recent Studies (post-2010) (ro 32-3555) | Studies (melagatran) | Trials (melagatran) | Recent Studies (post-2010) (melagatran) |
---|---|---|---|---|---|
15 | 1 | 4 | 185 | 32 | 19 |
Protein | Taxonomy | ro 32-3555 (IC50) | melagatran (IC50) |
---|---|---|---|
Prothrombin | Homo sapiens (human) | 0.5239 | |
Plasminogen | Homo sapiens (human) | 3.06 | |
Cationic trypsin | Bos taurus (cattle) | 0.0112 | |
Vitamin K-dependent protein C | Homo sapiens (human) | 1.3 | |
Trypsin-1 | Homo sapiens (human) | 0.0119 | |
Trypsin-2 | Homo sapiens (human) | 0.0119 | |
Coagulation factor VII | Homo sapiens (human) | 3.3 | |
Trypsin-3 | Homo sapiens (human) | 0.0119 |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Abbenante, G; Fairlie, DP; Leung, D | 1 |
1 review(s) available for ro 32-3555 and melagatran
Article | Year |
---|---|
Protease inhibitors: current status and future prospects.
Topics: Animals; Aspartic Acid Endopeptidases; Cysteine Endopeptidases; Cysteine Proteinase Inhibitors; Humans; Metalloendopeptidases; Models, Molecular; Protease Inhibitors; Serine Endopeptidases; Serine Proteinase Inhibitors | 2000 |